Beck Bode LLC’s Nu Skin NUS Stock Holding History

Beck Bode LLC’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-450	Closed	-$25K	–	227
2021 Q2	$25K	Buy	+450	New	+$25.6K	0.01%	180
2020 Q4	–	Sell	-450	Closed	-$23K	–	188
2020 Q3	$23K	Buy	+450	New	+$21.3K	0.01%	158

Other funds holding NUS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Beck Bode LLC's NUS Position: Q3 2021 in Review

Beck Bode LLC sold out of Nu Skin (NUS) in Q3 2021, closing a stake of 450 shares — an estimated $25K sold.

Beck Bode LLC first reported a position in NUS in Q3 2020 and held it in 2 quarters. The position peaked at $25K in Q2 2021. 246 funds tracked by Wall St. Rank hold NUS as of Q3 2021.

Beck Bode LLC reported no remaining Nu Skin position as of Q3 2021 after selling out during the quarter.
Beck Bode LLC sold 450 Nu Skin shares in Q3 2021, an estimated $25K.
Beck Bode LLC first reported a position in Nu Skin in Q3 2020 and held it in 2 quarters.
Beck Bode LLC's Nu Skin position peaked at $25K in Q2 2021.
246 funds tracked by Wall St. Rank held Nu Skin as of Q3 2021.

Based on Beck Bode LLC's 13F filing for Q3 2021, filed 22 Oct 2021.